Why the study?
Does high-dose regular nebulized salbutamol compared to on-demand salbutamol reduce relapses and hospitalization duration in young hospitalized children with first acute rhinovirus-induced wheezing episode?
Does high-dose regular nebulized salbutamol compared to on-demand salbutamol reduce relapses and hospitalization duration in young hospitalized children with first acute rhinovirus-induced wheezing episode?
High-dose inhaled salbutamol may interact with oral prednisolone to reduce relapses in young children with a first episode of rhinovirus-induced wheezing.
Answers are grounded in this paper and cite their sources.
May support salbutamol-prednisolone interaction in reducing relapses; hypothesis-generating and requires randomized confirmation before practice change.
OBJECTIVE: -agonist with and without oral corticosteroid in the first acute rhinovirus-induced severe wheezing episode in young hospitalized children. METHODS: The study population came from two randomized controlled trials comparing oral prednisolone (2 mg/kg/d for 3 days) to placebo: Vinku (n = 35, NCT00494624) used high-dose regular nebulized salbutamol (0.15 mg/kg 2-4 h intervals) and Vinku2 (n = 60, NCT00731575, EudraCT 2006-007100-42) used inhaled salbutamol on-demand. Both studies used identical detailed follow-up assessments. The primary outcome of the former was the duration of hospitalization and of the latter the occurrence of and the time to a new physician-confirmed wheezing episode within 2 months after discharge. Treatment groups included salbutamol high-dose vs. salbutamol on-demand while adjusting for prednisolone status and acknowledging for interactions with exception of the duration of hospitalization in which prednisolone groups could not be fully used due to protocol differences. RESULTS: Median age of subjects was 13 months, 32% were sensitized and 22% had doctor-diagnosed eczema. In the duration of hospitalization, salbutamol high-dose/placebo versus salbutamol on-demand/placebo groups did not differ (p = .12). In the occurrence of and time to relapse within 2 months, a significant group × treatment interaction was observed (both p = .02), such that high-dose group had less and longer time to relapses than on-demand group in prednisolone arm (both p < .05), but no difference was detected in placebo arm (both p > .26). CONCLUSIONS: In young, hospitalized children with first episode of rhinovirus-induced wheezing, high-dose inhaled salbutamol may interact with oral prednisolone. However, further trials are warranted.
No takes yet. Share an insight, caveat, or question.
Hurme et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: